// STATE LEGISLATION TRACKER

Mississippi HB 59: Nurses; allow nurse practitioners and RNs to administer vitamins through IV therapy in a clinical setting.

⚖️ NEUTRAL for peptide users 👤 NONE user impact 📜 Status: Failed

State: Mississippi
Bill: HB 59
Session: 2026
Filed: 2026-01-07
Read the bill: OpenStates →
Last reviewed: 2026-10-02

Plain-English Summary

Mississippi HB59 would have allowed licensed nurse practitioners and registered nurses to administer IV fluids containing vitamins in a clinical setting. Based on the title and available bill summary, it does not regulate peptides, peptide prescribing, telehealth, controlled substances, or prescription monitoring.

Key Points

No direct change to access for compounded peptides.
No apparent change to off-label prescribing rules.
No telehealth provisions are indicated.
Applies to IV vitamin therapy, not peptide therapy.
No direct 503A or 503B peptide compounding change.

What to Watch For

Note The bill is limited to vitamins in IV therapy, so peptide clinics should not treat it as peptide authority.

✓

Opportunity If reintroduced, similar language could signal interest in expanding wellness-clinic nursing scope.

Note The compound-pharmacy language appears tied to vitamins only, not peptide compounding.

Where the Bill Stands

The bill died in the House Public Health and Human Services Committee on February 3, 2026.

· Ed. Our analysis pulls public bill metadata from OpenStates and is enriched with research-model context. We don't quote bill text we haven't read directly. If this bill matters to your practice or treatment access, read the official source linked above before taking action. We're an educational research directory, not a legal or medical reference.

Bill page generated 2026-11-04 · enriched via codex gpt-5.5
Source: OpenStates v3 API · View official bill · ← back to all laws